Tawi, Romelyn .

HRN: 22-40-07  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/28/2022
01/03/2023
IVT
375mg
Q6
URTI
Waiting Final Action 
12/31/2022
CEFUROXIME 1.5GM (VIAL)
12/31/2022
01/06/2023
İVT
500mg
Q8
Urti
Waiting Final Action 
12/31/2022
MUPIROCIN 2%, 15G (TUBE)
12/31/2022
01/05/2023
TOPICAL OU
Thinly
Bid
Skin Infection
Waiting Final Action 
12/31/2022
CEFTRIAXONE 1G (VIAL)
12/31/2022
01/05/2023
İVT
1,500mg
Od
Urti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: